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1  | INTRODUC TION
The degree of paralysis after administration of neuromuscular block-
ing agents (NMBA) can be assessed using a peripheral nerve stimu-
lator in subjective neuromuscular monitoring, or with an objective 
(quantitative) neuromuscular monitoring device, for example by means 
of acceleromyography.1 In a recent consensus statement, researchers 
in the field recommended that objective neuromuscular monitoring 
should be used whenever a non-depolarizing NMBA is administered 
to reduce morbidity associated with residual neuromuscular block.2 
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Background: Neuromuscular monitoring is recommended whenever a neuromuscu-
lar blocking agent is administered, but surveys have demonstrated inconsistent moni-
toring practices. Using qualitative methods, we aimed to explore barriers and aids to 
routine neuromuscular monitoring and consistent reversal practice.
Methods: Focus group interviews were conducted to obtain insights into the thoughts 
and attitudes of individual anaesthetists, as well as the influence of colleagues and 
department culture. Interviews were conducted at five Danish and one US hospital. 
Data were analysed using template analysis.
Results: Danish anaesthetists used objective neuromuscular monitoring when admin-
istering a non-depolarizing relaxant, but had challenges with calibrating the monitor 
and sometimes interpreting measurements. Residents from the US institution used 
subjective neuromuscular monitoring, objective neuromuscular monitoring was gener-
ally not available and most had not used it. Danish anaesthetists used neuromuscular 
monitoring to assess readiness for extubation, whereas US residents used subjec-
tive neuromuscular monitoring, clinical tests like 5-second head lift and ventilatory 
parameters. The residents described a lack of consensus between senior anaesthe-
siologists in reversal practice and monitoring use. Barriers to consistent and correct 
neuromuscular monitoring identified included unreliable equipment, time pressure, 
need for training, misconceptions about pharmacokinetics of neuromuscular blocking 
agents and residual block, lack of standards and guidelines and departmental culture.
Conclusion: Using qualitative methods, we found that though Danish anaesthetists 
generally apply objective neuromuscular monitoring routinely and residents at the 
US institution often apply subjective neuromuscular monitoring, barriers to consist-
ent and correct use still exist.
This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
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The importance of also monitoring the depolarizing block after suc-
cinylcholine was demonstrated in a study of awareness at emergence 
in patients with butyrylcholinesterase (BChE) deficiency.3 However, 
surveys and observational studies show that often, objective neu-
romuscular monitoring equipment is either not available or used 
inconsistently.4-9 Naguib and colleagues found that most anaesthe-
siologists in the United States (US) have access to subjective neuro-
muscular monitoring, but few had access to objective neuromuscular 
monitoring compared to their European colleagues.10 The survey also 
showed that even when both objective and subjective monitoring 
were available, US respondents were more likely to use the subjective 
method, though it did not address why. Furthermore, routine reversal 
of the neuromuscular block was less common among European re-
spondents.10 Already in 2005, most clinicians in Denmark had access 
to objective neuromuscular monitoring.11 However, a more recent 
survey found that 75% of Danish anaesthetists had technical difficul-
ties with the objective monitors at least 25% of the time.12 While the 
surveys have demonstrated a large variability in availability and use of 
neuromuscular monitoring equipment, little is known about potential 
barriers to anaesthetists’ routine use of neuromuscular monitoring.
Using qualitative methods, we aimed to explore barriers and aids 
to routine neuromuscular monitoring and consistent reversal practice.
2  | MATERIAL S AND METHODS
We conducted a qualitative study based on focus group interviews 
and surveys of anaesthesiologists’ and nurse anaesthetists’ clinical 
practice and used systematic text condensation to extract themes 
as described by Malterud.13
2.1 | Participants
Focus group interviews were conducted in Denmark between 
August 2014 and January 2015. When author JLDT was a visiting 
scholar at the Department of Anaesthesiology at Stanford Medical 
Center in the Spring of 2017, interviews were conducted with anaes-
thesia residents to explore differences and similarities between an 
institution that had not yet implemented objective neuromuscular 
monitoring and the previously obtained findings from Danish hospi-
tals. In Denmark, we recruited both smaller and larger departments. 
For the focus group interviews, we included certified and in-training 
anaesthesiologists and nurse anaesthetists (collectively referred to 
as ‘anaesthetists’).Participants were incentivized to stay after nor-
mal work hours with a gift certificate (approximate value of €30), 
resulting in a convenience-based sample. In the US, we included 
anaesthesia residents from the Department of Anaesthesiology at 
Stanford Medical Center. Three specific lectures were allotted as 
time slots for interviews with first, second- and third-year residents, 
respectively, resulting in a convenience-based sample. Secondly, we 
sent a survey to the attendings at the department and other anaes-
thesia residency programmes in California, US.
2.2 | Focus group interviews
We chose focus group interviews as the primary approach 
because group interaction would encourage respondents to 
explore and clarify individual and shared perspectives.14 An in-
terview guide (Appendix 1) was developed based on literature 
review and the authors’ expertise in the subject. Participants 
were informed that the purpose of the study was to get their 
view on neuromuscular monitoring and describe the challenges 
they experience with the subject. They were informed about po-
tential conflicts of interest. The author, JLDT, who had experi-
ence from a previous interview study,3 conducted the interviews 
as a research fellow in Denmark, and as a visiting scholar at the 
US institution. In Denmark, additional interviews were con-
ducted until data saturation was achieved as judged by author 
JLDT, whereas in the US, the interviews were limited to residents 
at a single programme. The interviews were recorded on a voice 
recorder and transcribed in their entirety by a research assistant 
or author JLDT.
2.3 | Survey of attendings
We designed an online survey to get the views of attending an-
aesthesiologists in the US institution on the subjects discussed by 
residents. The survey contained a total of 14 multiple-choice and 
open-ended questions. The survey was sent to attendings at the 
local institution and to two attendings at each of the ten other an-
aesthesia residency programmes in California.
2.4 | Ethics committee approval
According to Danish regulations, approval from the local ethical com-
mittee is not required for this type of studies. The Danish part of 
the study was registered at clinicaltrials.gov (NCT02239965). The 
Institutional Review Board at Stanford University approved the study 
protocol for the US part of the study (Protocol # 42091). Verbal con-
sent was obtained from all participants.
Editorial Comment
Inadequate monitoring of neuromuscular blockade and 
reversal of neuromuscular blocker drug effects can con-
tribute to preventable perioperative patient complica-
tions. This qualitative assessment of specialty physician 
approaches to these issues in two high-income countries 
and practices show that these issues remain an area where 
more education and better implementation of the best 
practice standards can be needed.
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2.5 | Analysis
Initially, the author JLDT read the transcripts freely, without coding 
or analysing. The transcript of one focus group interview was then 
coded, using a priori codes based on the interview guide and own ex-
pertise in the subject. Further codes were derived directly from the 
text as a part of the analysis. Initial coding of the Danish interviews 
was discussed and revised by the authors JLDT and DØ. The resulting 
codebook was used as a starting point for the coding of the remaining 
interviews. Finally, the survey responses were coded. All codes from 
both Danish and US data were plotted in concept maps to group re-
lated codes into themes and subthemes and demonstrate relations.15 
Quotes reported in the results were cleaned for slang phrases and 
condensed. Danish quotes were translated by author JLDT.
Findings are reported according to the Consolidated Criteria 
for Reporting Qualitative Research (COREQ) where appropriate.14 
Coding was performed in nVivo 11 for Mac (QSR international).
3  | RESULTS
We conducted 6 focus group interviews in 5 Danish teaching hos-
pitals, with five to seven participants in each interview, totalling 40 
interviewees. In the US, we conducted three interviews with a total 
of 21 anaesthesia residents. Surveys were completed by 22 local at-
tendings and by 13 attendings from other programmes in California. 
The duration of the focus group interviews was 37-65 minutes. 
Analysis of the interviews resulted in three major themes: Use of 
neuromuscular monitoring and reversal and Barriers and aids to routine 
neuromuscular monitoring, and Neuromuscular monitoring after suc-
cinylcholine. Table 1 and Appendix 2 show the themes with sub-
themes, codes and illustrative quotes.
3.1 | Theme 1: use of neuromuscular monitoring and 
reversal after non-depolarizing NMBA
The Danish and US anaesthetists generally had access to differ-
ent types of neuromuscular monitoring. Neuromuscular block was 
managed differently, depending on the equipment available, as 
shown in Figure 1. Danish anaesthetists stated that they always 
apply acceleromyography before administering the non-depolariz-
ing NMBA to check the control response, calibrate the monitor and 
guide timing of intubation. They would use the monitor to guide 
maintenance dosing of NMBA, timing and dosing of reversal, and 
readiness for extubation. The residents at the US institution had 
access to primarily subjective neuromuscular monitoring and would 
rarely apply it before administering the first dose of NMBA, but 
consistently apply it to guide maintenance dosing of NMBA and 
timing of reversal. They did not check a baseline response before 
administering NMBA, which sometimes led to confusion about 
whether the monitor was malfunctioning or the patient was still 
paralysed when no responses were observed. Residents often used 
a timer to assess readiness for tracheal intubation, stating 2 min-
utes as the usual time from administration of NMBA to intubation.
When reversing the neuromuscular blockade, Danish anaesthe-
tists would give a standardized non-weight-based dose of one vial 
(neostigmine 2.5 mg and glycopyrronium 0.5 mg) and then assess the 
effect with acceleromyography. They would then rely on the monitor 
for assessing readiness for extubation, often combined with clinical 
tests. The residents at the US institution and the attendings based 
their decision to administer reversal on a range of parameters: du-
ration of the case, time since last administration of NMBA (from 2 
to 6 hours) and subjective neuromuscular monitoring. Reversal dos-
ing was either based on subjective monitoring or the same standard 
weight-based dose was given to all patients. Some residents would 
always administer at least a small dose of neostigmine, referred to as 
a ‘legal reversal’. Some residents used train-of-four (TOF) and other 
stimulation patterns to assess readiness for extubation, whereas oth-
ers would use ventilatory parameters or other clinical tests instead.
3.2 | Theme 2: barriers and aids to routine 
neuromuscular monitoring
Based on the interview data, we identified barriers and aids to rou-
tine neuromuscular monitoring. As shown in Figure 2, we further 
found that attitudes and departmental factors could influence moni-
toring practice both negatively and positively, that is act both as bar-
riers and aids.
3.2.1 | Barriers
Though monitoring was readily available, even just storing the cable of 
the monitor in a drawer could pose a barrier to use of the equipment. 
Residents from the US institution mentioned faulty twitch monitors 
and flat batteries, and anaesthetists from both countries reported 
unreliable equipment leading to not trusting its measurements. Time 
pressure was also given as an explanation for not monitoring and the 
patients having arms tucked under surgical drapes and not easily acces-
sible was another cause for frustration. There was a need for training 
in the setup and interpretation of objective neuromuscular monitor-
ing, the purpose of calibration and risk stratification of residual block 
vs side effects from neostigmine reversal, knowing the limitations of 
subjective monitoring, and, in Denmark, managing acceleromyography 
showing TOF ratios greater than 100%. Several local attendings also 
requested training in objective neuromuscular monitoring.
3.2.2 | Attitude
The attitude of both the anaesthetist and the attending in charge of 
patient care was found to influence whether monitoring was applied. 
While both Danish and US anaesthetists considered residual neuro-
muscular block a serious complication and stated that minor degrees 
1092  |     THOMSEN ET al.
TA B L E  1   Barriers and aids to routine neuromuscular monitoring
Subtheme Code Source Quote or observation
Barriers Residual block 
unrecognized
DK-1 But the others, where it is not discovered until the patient cannot cough sufficiently, and so 
on, and gets pneumonia, they are probably underreported.
 Residual block 
unrecognized
US-3 I think there are patients with residual block in the PACU and we may clinically by vital signs 
not notice or it may not be obvious to us.
 Residual block 
unrecognized
US-3 Well, I think that we have heard many patients say that they're a little weak or groggy or 
whatever—how much of that is just our hand waving ‘oh that's normal after surgery and 
anaesthesia’ vs what is residual block? I don't think I can say, confidently.
 Residual block 
unrecognized
US-1 It was an obese woman in the PACU, saturating 75%, blue. And we gave 400 of sugammadex 
and she was totally fine, and I thought ‘oh, that does happen’. [Attending] was there and 
she said ‘look, she's kind of twitching, this is what residual neuromuscular block looks like’. 
Because I said ‘let's give flumazenil too’ and she said ‘no, let's just give sugammadex and see 
what happens’. And she perked right up.
 Equipment 
placement
DK-5 We remove [the cable of the monitor] and put in the drawer when it is not in use. I actually 
managed to take the cable from the drawer, and put it on the patient without plugging it 
into the monitor. It took me a while to find the source of the error.
 Equipment 
placement
US-2 The twitch monitors that they do have, some of them are tethered to the anaesthesia 
machine, so either it doesn't reach and you have to pull your machine closer or it dangles in 
your way and gets tangled in your lines and it's just an inconvenience or it doesn't work, the 
battery's out.
 Reliability US-3 And the problem with the questionable working [peripheral nerve stimulators] is you don't 
know if it's not working or if you don't have twitches… (...) often times you'll get another one 
and then that one doesn't work either—or do I not have twitches?
 Reliability DK-3 I always use neuromuscular monitoring when using non-depolarizing blockers, but I do not 
trust it completely because it always calibrates to more than 100%
 Reliability DK-2 That is probably also why many anaesthesiologists, myself included, get tired of the 
equipment when it does not work: the patient is awake and breathing fine, and the TOF 
monitor says ‘0’. You get furious and tear it off. Then the problem arises when it says ‘0’ and 
the patient is actually paralysed, but you still tear it off and throw it away and awaken them. 
That would be a mistake, of course, but that is because we do not have equipment that is 
100% reliable and you become insecure about its performance, and was it calibrated or not? 
and can you count on it?
 Reliability US-2 A lot of time you can't get a good signal and you cannot get [the quantitative monitor] to go 
correctly and then you just ignore it.
 Time pressure US-2 …if it wasn't like 11 pm at night and there wasn't like this production pressure to get it done, 
we should have stayed in the OR for fifteen minutes, while it was like ‘oh it's okay, it'll be 
fine’ and then we had to re-intubate in the PACU and wait for forty minutes.
 Time pressure US-3 I still probably wouldn't use it because you have to do it before you give paralysis, but we 
usually are in such a rush, once you start sedating you're going to give the paralysis. I don't 
have time to put on another monitor, give sedation, check, calibrate the accelerometer and 
then give paralysis and intubate. It's too much of a hassle for too little gain.
 Arms tucked DK-2 There is often the challenge with one arm being tucked down the sides, and you have to put 
two venous catheters, an arterial canula, a TOF monitor, and a pulse oximeter, and it all goes 
into that one arm.
 Arms tucked US-2 [With the arms tucked, the objective monitor] is not reading correctly, so you have to get 
their hand like correctly and clearly they have a good strong twitch, but because of the way 
their thumb is going down it is not reading and so, it becomes useless to me.
Attitude Necessity DK-2 If you are doing a procedure where you only need paralysis for intubation and the procedure 
is less than an hour or so, I think monitoring of the block is quote-unquote redundant, 
because of what we know about pharmacokinetics and so on, it should be eliminated long 
before we awaken the patient—using those 15-20 mg doses [of rocuronium]
 Necessity US-3 The IVs and art lines are in the way, I feel like it's more trouble than benefit, unless there's 
a specific indication that I want to like very closely objectively monitor paralysis, but that 
would be so rare I wouldn't use it regularly
(Continues)
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Subtheme Code Source Quote or observation
 Necessity US-1 Well, I think there is just a sense of that we get a good enough sense of where we're at 
[with subjective monitoring]. Maybe people are a little more cavalier too, with having 
sugammadex because you always have something to fall back on if any problems were to 
occur.
 Necessity US-1 I know that the quantitative machine can tell you a lot more, but I’ve yet to encounter an 
instance where someone was still weak based on the non-quantitative approach
 Significance of 
residual block
US-3 How clinically significant is a minor residual paralysis in most patients if they're able to 
cough, but they're still a little weak? [other residents agreeing: ‘yeah’ and ‘right’] They're 
going to be in the PACU sort of groggy for an hour anyway, not knowing, not remembering 
(…) we probably have patients who have residual paralysis, but for a lot of them it doesn't 
become clinically relevant.
 Significance of 
residual block
DK-1 Well, it is a serious matter if they cannot breathe when you pull the tube if you did not realize 
it. Very much so, psychologically, but it is also dangerous if re-intubation is difficult and 
you cannot get them sedated deeply enough. So, it would certainly be a problem, if it were 
something we experienced often.
 Experience with 
residual block
US-3 In the PACU, where I saw a lot of patients having residual paralysis, where the intraoperative 
team was convinced that they had been reversed, also sort of changed my practice of 
making sure you are checking before and after you have given reversal. Because often 
times, they haven't checked after.
 Experience with 
residual block
US-2 I have had it happen twice. (…) and it was also like a fairly short case and I think my attending 
said ‘yeah, it should be okay, I think it'll be fine’. We gave a full dose [of neostigmine] and 
then, in the PACU she was in respiratory distress and had to be re-intubated, she was 
hypoxic, 91%.
 Experience with 
residual block
DK-1 I do not know how many years back it was since we had someone with severe residual 
neuromuscular block, but it must be some years back, because I am in the patient safety 
group, and I do not recall that there has been a case in the last 3-4 years.
 Experience with 
residual block
US-2 Objectively it seemed okay, but then as soon as we got to PACU, we had to reintubate and sit 
with the patient for half an hour. So, you can get fooled even if they're bucking.
 Attending 
consensus
US-1 It does feel a little bit like the wild, wild west where people just kind of do what they want. 
(…) individual practice vary so widely which is really frustrating as a trainee, cause you're 
just like ‘what am I supposed to do? What do you want me to give?’ and it really varies from 
attending to attending
 Attending 
attitude
US-1 Part of the challenge too is the papers that looked [at residual block] will often talk about 
how they don't even checked twitches. And so, I think, when I talk to attendings about this 
they sort of spin it like ‘well that was just gross negligence and certainly doesn't apply to my 
practice’.
 Attending 
attitude
US-3 They had given reversal and the patient had a prolonged wake-up, and the patient was large, 
had obstructive sleep apnoea and had had thoracic surgery and wasn't taking great breaths 
and was obstructing and it seemed like the anaesthetic had worn off. So, we got a twitch 
monitor and I didn't see great twitches. I talked to the attending and said: ‘I’m going to give 
sugammadex reversal’, the attending said ‘no, the patient was fully reversed, I don't agree’. 
Then I couldn't really do anything, I kept on checking and then I just gave [sugammadex] and 
then they were fine.
 Attending 
attitude
US-3 It would have to be something that we've been taught as a first-year resident and on. And 
it has to be uniform by the attendings, it can't be like some attendings saying ‘don't worry 
about it’. It's like when they want us to start using the sterile kit for the arterial line, some 
attendings say ‘yes, use it’, some attendings say ‘I don't care’. If you offer the lazier thing as 
okay, then I’m going to take the lazier one—unless there is some important indication to do 
the harder work.
 Attending 
attitude
US-3 If we want to use [objective neuromuscular monitoring] at the [other hospital], then the 
attendings will be fine with it, but sometimes the attendings want to use it then we use it.
Sometimes, attendings don't care.
Department Equipment 
availability
US [On subjective neuromuscular monitoring] It is not always immediately available in every 
room
TA B L E  1   (Continued)
(Continues)
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Subtheme Code Source Quote or observation
 Equipment 
availability
DK-1 We have the objective neuromuscular monitoring module in all our machines
  DK-5 It is more readily available now, because before, we were running around, asking where the 
monitor was. Even though we had 4 or 5 it felt like they were always missing.
 Equipment 
availability
DK-1 In [one department], we have to go look for them, whereas in [other department], it is 
available in the operating rooms.
 Availability/
experience
US-1 At [other hospital], I think they have a hookup to actually do quantitative, never seen it used
I’ve used it once at the [other hospital]
I’ve never used it. I never even knew we had it, I had no idea that was an option.
 Culture US-1 Where I went to medical school and did a good amount of anaesthesia, we always hooked 
up to the larger monitor where you actually get a quantitative value of your train-of-four, 
it was just one of the monitors that you put on at the beginning of the anaesthesia every 
time, just like blood pressure or EKG. I found it very odd when I arrived here and no one did 
and we seem to use the twitch monitor in a heterogeneous way, it was very different from 
attending to attending. I guess I have adapted now, but at first it seemed strange.
 Culture DK-1 I perfectly understand that, if you come from a place where you are used to routinely apply 
monitoring in all cases, and then you are at a new place and you are constantly questioned 
about why you are doing it and they do not do it here, and then you sort of go ‘well, okay 
then’.
 Culture DK-1 I had my first year of residency at [other hospital] where if you did not redose rocuronium, 
you would not monitor the block and you would awaken the patient after an hour and test 
for residual block by having the patient lift their arm.
 Culture US-2 I mean I think the culture here is that you know prolonged paralysis or re-curarization after 
reversal is like really dangerous and it's like a safety concern
 Standardization US-1 Just standardization of practice is helpful as well, especially with like neostigmine, because it 
seems it was all over the place
 Practice vs 
guidelines
DK-4 It may be a bit self-contradictory, but I did write in the standard operating procedure, that 
you have to [use monitoring] if you give a NMBA. But I have to be honest and confess that if 
I used succinylcholine for a rapid sequence induction, I will rarely put a TOF monitor on.
Aids Integration of 
NM
DK-5 Because you see it much more frequently. You are staring at the [monitor] all the time 
anyway. Instead of going ‘oh, I have to check the TOF monitor, too. Oh, my—32%,’! Now 
you see it all the time, and check everything on the screen. You look up, and then your eyes 
naturally pass the lower right corner.
 Routine DK-2 I hardly think we have any patients who receive rocuronium without being monitored
 Legal 
consequences
US-1 Many attendings have been like ‘this is an easy box to check if there is a claim into this case—
if there's any question as to whether you assessed neuromuscular block, could you defend 
this in court?’ Which is not a good reason to do anything in this country, but it is a part our 
allegiance
 Reliability DK-1 A condition for wanting to use any equipment is simply knowing that it works every time, 
which is true for the new monitor.
Need for training Setup US (S) [I would like training in] how to place a quantitative device so that data are reliable
 Setup US-2 [I would like] being able to assess the twitches on the hands, even when they're tugged, 
instead of just being lazy and putting it on the head
 Request training US-3 [I would like] training in [objective neuromuscular monitoring] so we know how to use it 
instead of just having it available
 Calibration DK-5 If it will not calibrate, that is a situation where I wonder ‘how does it actually affect the 
measurements’?
 Calibration US-3 You can apply it [accelerometry without calibration], it's just not calibrated so the usefulness 
of it, how objective it really is, is also in question and it's harder to interpret.
 Troubleshooting DK-5 I don't understand why it always calibrates to 1.14 or something else above 1.0
TA B L E  1   (Continued)
(Continues)
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Subtheme Code Source Quote or observation
 Risk stratification US-1 [What are] the patient populations that are truly going to be affected by this? Who is not 
reversed adequately? Who is super sensitive to non-depolarizing? Because if you have a 
lot of these healthy patients where you give it and it doesn't do anything to change their 
outcome, or you don't give it and it doesn't do matter. And then your sick patients for whom 
you could really make a difference in your quality of care.
NM after 
succinylcholine
No pain DK-3 Let us say, then, that you had an awareness experience, and you were lying there after a 
short procedure—you are not having surgery at that time, so there is no pain. There is the 
feeling of suffocation, that is certainly not comfortable, either, but it is not major heart 
surgery or emergency caesarean section.
 BChE rare DK-1 There are many things we see once, or has happened in the last 10 years at this hospital, but 
that does not necessarily lead to a bigger change, because then you would have to change 
things all the time, which perhaps induces uncertainty because people are not confident in 
what they are doing.
 BChE deficiency 
often known
DK-1 But it is often caught in the pre-anaesthetic assessment if someone in the family had BChE 
deficiency
 Will be 
discovered 
eventually
US-2 No, I think probably if at the end of the case you run into trouble and somebody looks weak, 
then you might do it, but not routinely.
 Will be 
discovered 
eventually
US-3 I mean I guess you checked twitches once you found out, right? So, whether you checked at 
the beginning of the case or at the end of a case it wouldn't have really made a difference.
 Will be 
discovered 
eventually
US-1 I put them on pressure support at the end and see if they breathe. If they didn't then I’d go 
down that pathway.
 Over-
complicating
DK-1 It is also a question of not making a relatively simple procedure into a big thing. As soon 
as you start putting more wires on the patient and doing stuff, then maybe they need a 
central venous catheter, too, and then they all get an arterial canula. How intensely should a 
perfectly healthy patient having a 15-minute gastroscopy be monitored?
 Over-
complicating
DK-3 I also think that sometimes with the short procedures, we spent some time [applying 
monitoring] and resources that could have been spent differently, because you know what 
the half-life is. And if there is a problem, you put the monitor on.
 Time pressure DK-4 You should not underestimate the effect of this being a production, and it has to run 
smoothly, and we should not prolong patient turnover times
 Experience 
changing 
behaviour
US-3 And then I usually always check at least once after I’ve given it to put in document, but that's 
because I’ve had a case where I gave it and then four hours later didn't check it prior to 
wean somebody of the ventilator and then they were still paralysed and I realized that they 
had pseudocholinesterase deficiency. So now I check everybody
 Experience 
not changing 
behaviour
DK-1 Well, we do have a colleague who was anaesthetized and she had [BChE deficiency]. And 
she did not think it was particularly funny to wake up, and get succinylcholine, and not 
being able to breathe, so… Maybe we should consider it, but we have given it so many times 
without.
 Experience US-3 It was during my PACU rotation, patient just didn't move after surgery, so we brought her out 
on the ventilator and they had to extubate her like a couple of hours later. And we thought 
that it was most likely pseudocholinesterase deficiency and she hadn't mentioned anything 
but she had had surgery years before and was like ‘oh, yeah it took me a while to wake up’.
 Routine DK-5 I never used the monitor for rapid sequence induction, did you?
If only using succinylcholine? I never did that.
I used to do it in the old days, but now, I mostly do not
 Before non-dep. DK-3 But it does not have to be on for intubation with succinylcholine, but it is applied and turned 
on before administering rocuronium.
 Before non-dep. US-1 And I try to remember to always check it if I gave succinylcholine before I give rocuronium to 
make sure that the twitches came back.
Note Themes, subthemes, codes and illustrative quotes from focus group interviews and surveys in Denmark (DK) and the institution in the United 
States (US). The number after ‘DK’ indicates department number, whereas the number after ‘US’ indicates year of residency for the interviewee. ‘S’ 
indicates data from surveys.
Abbreviations: BChE, butyrylcholinesterase; NMBA, neuromuscular blocking agent, TOF, Train-of-four.
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of residual block were probably underdiagnosed, some residents at the 
US institution did express that minor degrees of residual block would 
not necessarily be clinically relevant. Some residents could not imag-
ine routine application of objective neuromuscular monitoring being 
worth the effort. Some Danish anaesthetists would omit neuromuscu-
lar monitoring only if a reduced dose of 15-20 mg rocuronium was used. 
Several residents at the US institution had experienced cases with se-
vere residual neuromuscular block, sometimes requiring tracheal re-
intubation, whereas only a few Danish anaesthetists had experienced 
severe residual neuromuscular block. Senior Danish anaesthesiologists 
described cases from years prior, when the long-acting NMBA pancu-
ronium was used routinely. Personal experiences with patients with re-
sidual block sometimes led to a change in the anaesthetist s´ behaviour 
with regard to neuromuscular monitoring, but not always. Both Danish 
and US anaesthetists described instances where senior colleagues 
would not acknowledge that the patient had residual neuromuscular 
block. The residents expressed the importance of consensus between 
the attendings regarding the necessity and practice of neuromuscular 
monitoring and reversal. A resident noted that some attendings were 
perhaps reluctant to acknowledge that studies of residual block ap-
plied to their own practice.
3.2.3 | Department
In Denmark, objective acceleromyographic neuromuscular monitor-
ing equipment was available in almost every operating room and 
integrated in the anaesthesia machine. At the US institution, resi-
dents had access to subjective neuromuscular monitoring either in 
every room or upon request. Objective neuromuscular monitoring 
was only available at one centre where residents rotated through 
in their training, but only few had experience using it. The surveyed 
attendings at other institutions reported a similar pattern of having 
subjective neuromuscular monitoring available either in every oper-
ating room or upon request, with objective neuromuscular monitor-
ing available at a single site, upon request, or not at all. Both Danish 
and US anaesthetists discussed how department culture can influ-
ence monitoring behaviour:monitoring routines from a former work-
place could be ‘unlearned’ when changing to a department with a 
different monitoring culture. The lack of a standard approach or a 
guideline regarding reversal was a cause for frustration among some 
residents, but on the other hand, a Danish anaesthetist reported 
not applying neuromuscular monitoring after succinylcholine even 
though he himself had written the guideline mandating monitoring.
3.2.4 | Aids
Danish anaesthetists described it as helpful to have the TOF meas-
urements shown directly on the monitoring screen. Both Danish 
and US anaesthetists discussed the importance of having reliable 
equipment, and most Danish anaesthetists were of the opinion 
that the current integrated equipment was better than the stand-
alone monitoring devices that had been available before. Some 
residents from the US institution described how they applied 
monitoring solely so they could document it in case a claim was 
filed.
3.3 | Theme 3: neuromuscular monitoring after 
succinylcholine
While some barriers, like time-pressure and ‘keeping it simple’, also 
affected application of neuromuscular monitoring after succinyl-
choline, some arguments against routine monitoring were unique. 
Opinions expressed included that BChE deficiency is so rare, that 
F I G U R E  1   Typical management of neuromuscular block, depending on type of equipment available. Red: objective neuromuscular 
monitoring, blue: subjective neuromuscular monitoring (twitch monitor). AIMS, anaesthesia information management system; NM, 
neuromuscular monitoring; NMBA, neuromuscular blocking agent; TOF, train-of-four [Colour figure can be viewed at wileyonlinelibrary.com]
F I G U R E  2   Barriers and aids to neuromuscular monitoring. ‘Barriers’ and ‘Aids’ are shown in red and green, respectively, whereas 
‘Attitude’ and ‘Department’ are shown in yellow because they can influence behaviour in either way. The orange box shows factors 
specifically influencing monitoring behaviour when succinylcholine is administered. BChE, butyrylcholinesterase; non-dep, non-depolarizing 
[Colour figure can be viewed at wileyonlinelibrary.com]
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if paralysed at the end of anaesthesia the patient would not feel 
pain, that patients with BChE deficiency will often know beforehand 
and warn the anaesthetist, or that the deficiency will be discovered 
eventually, anyway, by the patient not breathing. In some instances, 
a single experience with severe residual block after succinylcholine 
was enough to make the anaesthetist apply monitoring routinely, 
whereas at one Danish hospital, most anaesthetists did not apply 
routine monitoring despite having a colleague who had severe BChE 
deficiency and had shared her story of being awake while paralysed.
4  | DISCUSSION
4.1 | Use of neuromuscular monitoring and reversal
The US residents mostly used a timer to assess readiness for intu-
bation, whereas the Danish anaesthetist relied on objective neuro-
muscular monitoring, some stating TOF count 1 or 2 as appropriate 
for intubation. Arguments could be made for and against both ap-
proaches: Some variability in the onset of neuromuscular blockers 
must be expected in all patients, especially those with organ disease 
and with varying doses.16,17 On the other hand, the appropriateness 
of relying on neuromuscular monitoring would also depend on at 
what TOF value one chooses to perform intubation, as peak relaxa-
tion at the larynx and mandible precedes that at the adductor pol-
licis.18 The type and dosage of hypnotics and opioids also influences 
intubation conditions.18 We suggest to use objective (and automatic) 
neuromuscular monitoring with stimulation every 12th second com-
bined with a timer. Laryngoscopy may then be initiated after at least 
1.5 minutes and a TOF count of 1 or 0, likely resulting in intubation 
at TOF count 0. This is debatable.
The US residents used subjective neuromuscular monitoring 
and clinical tests to assess for readiness for extubation or need for 
reversal. The limitations of subjective neuromuscular monitoring to 
detect residual block has been established and it has therefore been 
suggested to administer at least a small dose of neostigmine to all 
patients.19,20 However, not all residents were aware of this approach. 
The clinical tests are also unreliable in assessing readiness for ex-
tubation.21 Finally, the attendings use varying approaches, often 
stating time since last dosage of NMBA as a reference for need for 
reversal. It is therefore understandable that residents rely on heu-
ristics like ‘time since last dosage of NMBA’ to decide whether to 
administer reversal, as also described in a Brazilian study, though this 
is not optimal practice.22 There is, however, a large variability in the 
duration of action of the non-depolarizing NMBAs with intermediate 
action, as more than a third of patients will have a TOF ratio <0.9 two 
hours after a standard intubation dose of two times the ED95.
23 Most 
Danish anaesthetists would monitor the TOF ratio continuously and 
omit reversal as appropriate. When necessary, they would use a 
standard non-weight-based dose of neostigmine and follow the TOF 
response on the monitoring screen, re-dosing reversal if needed 
until a TOF ratio >0.9 was achieved. For the average patient weigh-
ing 70 kg, this neostigmine dosing corresponds to 35 µg/kg, which is 
close to the 30 µg recommended as a minimal dose when objective 
neuromuscular monitoring is not available.20 Since the response to 
the standardized dose is directly observed with TOF measurements 
typically every 12 seconds, re-dosing of reversal or extubation can 
be performed as appropriate. The residents reported a varying 
dosing of neostigmine, with some routinely administering at least 
a small dose as recommended under the circumstances.20 While 
this small dose is unlikely to cause serious side effects, it is worth 
noting that neostigmine can be omitted completely when objec-
tive neuromuscular monitoring documents complete recovery. This 
difference in neostigmine dosing habits depending on equipment 
availability was also demonstrated in a survey of US and European 
anaesthesiologists.10
4.2 | Barriers and aids to routine 
neuromuscular monitoring
For four decades, there has been a strong tradition for research 
and training in neuromuscular monitoring in Denmark, and The 
Danish Anaesthesia Society recommends that objective neuro-
muscular monitoring should be used with non-depolarizing NMBAs 
and considered with succinylcholine.24 The American Society of 
Anesthesiologists’ standards for anaesthetic monitoring, on the 
other hand, do not mention neuromuscular monitoring,2 whereas 
their guideline for post-anaesthetic care from 2013 only mentions 
that ‘Assessment of neuromuscular function primarily includes 
physical examination and, on occasion, may include neuromus-
cular blockade monitoring’.25 It is not enough, however, just to 
make objective neuromuscular monitoring available and manda-
tory.2 We found that the attitude of both the residents and the 
attendings influenced the use of neuromuscular monitoring, with 
many of the residents not appreciating a potential benefit of ob-
jective neuromuscular monitoring over subjective. For department 
culture to change, training in neuromuscular monitoring should 
be consistent and lead by clinicians with experience using the 
equipment, and surveys of residual neuromuscular block should 
be conducted locally to increase awareness.2,8,9 The interviews 
with Danish anaesthetists also revealed a need for further train-
ing in the purpose of calibration of the objective neuromuscular 
monitoring device and dealing with TOF ratios >1.0, as was also 
described in a recent Danish survey.12 A challenge identified was 
placing the monitor when the patient's arms were tucked to the 
sides. Electromyography, as opposed to acceleromyography, could 
potentially eliminate this challenge because it does not require a 
freely moving thumb.2 A further advantage of electromyography 
would be a control TOF ratio closer to 1.0.26 We found that even 
when objective neuromuscular monitoring was available, the resi-
dents at the US institution were reluctant to use it, either from 
lack of training or because they did not find it necessary. In a sur-
vey from 2010, US respondents were also less likely to use objec-
tive neuromuscular monitoring than European respondents, even 
if both subjective and objective monitoring were available.10
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Both in Denmark and the US institution, anaesthetists agreed 
that residual neuromuscular block is a serious complication and that 
it probably occurs more frequently than experienced. This in concor-
dance with surveys of anaesthesiologists’ opinions and attitude about 
residual neuromuscular block, where the incidence is often underes-
timated and thought to be higher in colleagues’ practices.6,11,22 In a 
recent study assessing the incidence of residual neuromuscular block 
in 10 US hospitals, including the institution studied, 65% of patients 
receiving a non-depolarizing NMBA had a TOF ratio <0.9 at extuba-
tion.27 Though our study was not quantitatively designed, it is worth 
noticing that several of the residents at the US institution had experi-
enced cases with severe residual neuromuscular block, including need 
for re-intubation, already within the first years of training, whereas in 
Denmark, only senior consultants reported that type of experience.
4.3 | Neuromuscular monitoring after 
succinylcholine
Although patients with undiagnosed BChE deficiency are at high risk 
of experiencing awareness during emergence if neuromuscular mon-
itoring is not applied, neither Danish anaesthetists nor the residents 
monitored the depolarizing block routinely.3 Both Danish and US 
anaesthetists reported senior colleagues who would not acknowl-
edge residual neuromuscular block due to BChE deficiency, as was 
also described in a study of cases from the Danish BChE registry.3
4.4 | Strengths and limitations
The Danish part of the study included focus group interviews with 
both nurse anaesthetists and anaesthesiologists with a range of ex-
perience, from hospitals of varying size, resulting in a reasonably 
representative sample of the 30 public anaesthesia departments 
in Denmark. On the other hand, findings from our sample of three 
groups of US anaesthesia residents is not representative of anaes-
thesia practice across the US, but may still provide relevant input to 
the process of implementation of objective neuromuscular monitor-
ing. The interviews in Denmark and the US were conducted three 
years apart. If and how this might have affected our findings remains 
unknown.
4.5 | Implications
While almost fully implemented in Denmark, objective neuromus-
cular monitoring still poses challenges in daily clinical practice. 
Training is needed in troubleshooting the potential pitfalls that 
exist with these devices which are not described in standard an-
aesthesia textbooks. Continuing medical education in this topic 
could include e-learning modules that can easily be disseminated 
to a larger audience.28 In US institutions that aim to implement ob-
jective neuromuscular monitoring, residents should be motivated 
to use the equipment not only by the reduction of residual neu-
romuscular block and postoperative pulmonary complications, but 
also the potential to simplify assessment of need for reversal and 
readiness for extubation. There is still a need for a culture change, 
also among senior anaesthesiologists, putting an end to the incor-
rect belief that they can rely on subjective neuromuscular monitor-
ing to rule out residual neuromuscular block.29 The US institution 
studied is in the process of implementing objective neuromuscular 
monitoring, bearing the described barriers in mind, and has devel-
oped a CME accredited e-learning module about objective neuro-
muscular monitoring and residual neuromuscular blockade.
5  | CONCLUSION
Using qualitative methods, we found that though Danish anaesthe-
tists generally apply objective neuromuscular monitoring routinely 
and residents at the US institution often apply subjective neuromus-
cular monitoring, barriers to consistent and correct use still exist. 
They include unreliable equipment, time pressure, need for training, 
misconceptions about NMBA pharmacokinetics and residual block, 
lack of standards and guidelines and departmental culture.
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